Cargando…
Correction: Novel fusion protein PK5-RL-Gal-3 C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114448/ https://www.ncbi.nlm.nih.gov/pubmed/37076852 http://dx.doi.org/10.1186/s12885-023-10843-0 |
| _version_ | 1785028017309876224 |
|---|---|
| author | Gao, Xiaoge Jiang, Pin Wei, Xiaohuan Zhang, Wei Zheng, Jiwei Sun, Shishuo Yao, Hong Liu, Xiangye Zhang, Qing |
| author_facet | Gao, Xiaoge Jiang, Pin Wei, Xiaohuan Zhang, Wei Zheng, Jiwei Sun, Shishuo Yao, Hong Liu, Xiangye Zhang, Qing |
| author_sort | Gao, Xiaoge |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10114448 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101144482023-04-20 Correction: Novel fusion protein PK5-RL-Gal-3 C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity Gao, Xiaoge Jiang, Pin Wei, Xiaohuan Zhang, Wei Zheng, Jiwei Sun, Shishuo Yao, Hong Liu, Xiangye Zhang, Qing BMC Cancer Correction BioMed Central 2023-04-19 /pmc/articles/PMC10114448/ /pubmed/37076852 http://dx.doi.org/10.1186/s12885-023-10843-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Gao, Xiaoge Jiang, Pin Wei, Xiaohuan Zhang, Wei Zheng, Jiwei Sun, Shishuo Yao, Hong Liu, Xiangye Zhang, Qing Correction: Novel fusion protein PK5-RL-Gal-3 C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity |
| title | Correction: Novel fusion protein PK5-RL-Gal-3 C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity |
| title_full | Correction: Novel fusion protein PK5-RL-Gal-3 C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity |
| title_fullStr | Correction: Novel fusion protein PK5-RL-Gal-3 C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity |
| title_full_unstemmed | Correction: Novel fusion protein PK5-RL-Gal-3 C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity |
| title_short | Correction: Novel fusion protein PK5-RL-Gal-3 C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity |
| title_sort | correction: novel fusion protein pk5-rl-gal-3 c inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114448/ https://www.ncbi.nlm.nih.gov/pubmed/37076852 http://dx.doi.org/10.1186/s12885-023-10843-0 |
| work_keys_str_mv | AT gaoxiaoge correctionnovelfusionproteinpk5rlgal3cinhibitshepatocellularcarcinomaviaantiangiogenesisandcytotoxicity AT jiangpin correctionnovelfusionproteinpk5rlgal3cinhibitshepatocellularcarcinomaviaantiangiogenesisandcytotoxicity AT weixiaohuan correctionnovelfusionproteinpk5rlgal3cinhibitshepatocellularcarcinomaviaantiangiogenesisandcytotoxicity AT zhangwei correctionnovelfusionproteinpk5rlgal3cinhibitshepatocellularcarcinomaviaantiangiogenesisandcytotoxicity AT zhengjiwei correctionnovelfusionproteinpk5rlgal3cinhibitshepatocellularcarcinomaviaantiangiogenesisandcytotoxicity AT sunshishuo correctionnovelfusionproteinpk5rlgal3cinhibitshepatocellularcarcinomaviaantiangiogenesisandcytotoxicity AT yaohong correctionnovelfusionproteinpk5rlgal3cinhibitshepatocellularcarcinomaviaantiangiogenesisandcytotoxicity AT liuxiangye correctionnovelfusionproteinpk5rlgal3cinhibitshepatocellularcarcinomaviaantiangiogenesisandcytotoxicity AT zhangqing correctionnovelfusionproteinpk5rlgal3cinhibitshepatocellularcarcinomaviaantiangiogenesisandcytotoxicity |